Pyoderma gangrenosum after totally implanted central venous access device insertion

World Journal of Surgical Oncology

Volumn 6, Issue , 2008, Pages

  Inan, Ihsan ^a   Myers, Patrick O ^a   Braun, Rolf ^a   Hagen, Monica E ^a   Morel, Philippe ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CEFEPIME; CORTICOSTEROID; IMIPENEM; TEICOPLANIN; TROPONIN; VANCOMYCIN; IMMUNOSUPPRESSIVE AGENT;

AGED; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CENTRAL VENOUS CATHETER; DEATH; DEVICE REMOVAL; DISEASE COURSE; DYSPNEA; EARLY DIAGNOSIS; ELECTROCARDIOGRAM; FEVER; HEART MUSCLE ISCHEMIA; HUMAN; KIDNEY FAILURE; LABORATORY TEST; LEUKOCYTE COUNT; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; NEUTROPHIL COUNT; POSTOPERATIVE PERIOD; PYODERMA GANGRENOSUM; REFRACTORY ANEMIA; SKIN INFLAMMATION; SKIN NECROSIS; THROMBOCYTOPHERESIS; CENTRAL VENOUS CATHETERIZATION; INDWELLING CATHETER; MALE;

AGED; AGED, 80 AND OVER; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYELODYSPLASTIC SYNDROMES; PYODERMA GANGRENOSUM;

EID: 41549143578     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-6-31     Document Type: Article

References (13)

1. Hachem R Raad I Prevention and management of long-term catheter related infections in cancer patients Cancer Invest 2002, 20:1105-1113 10.1081/ CNV-120015984 12449743
2. Reichrath J Bens G Bonowitz A Tilgen W Treatment recommendations for pyoderma gangrenosum: An evidence-based review of the literature based on more than 350 patients J Am Acad Dermatol 2005, 53:273-283 10.1016/ j.jaad.2004.10.006 16021123
3. Su WP Davis MD Weenig RH Powell FC Perry HO Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria Int J Dermatol 2004, 43:790-800 10.1111/j.1365-4632.2004.02128.x 15533059
4. Cullen TS A progressively enlarging ulcer of the abdominal wall involving skin and fat, following drainage of an abdominal abscess apparently from appendiceal origin Surg Gynecol Obstet 1924, 38:579-582
5. Brunsting L Goeckerman W O'Leary P Pyoderma gangrenosum: Clinical and experimental observations in five cases occuring in adults Arch Dermatol 1930, 22:655-680
6. Oka M Berking C Nesbit M Satyamoorthy K Schaider H Murphy G Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts Lab Invest 2000, 80:595-604 10780675
7. Yeon HB Lindor NM Seidman JG Seidman CE Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q Am J Hum Genet 2000, 66:1443-1448 10.1086/302866 10729114
8. Weenig RH Davis MD Dahl PR Su WP Skin ulcers misdiagnosed as pyoderma gangrenosum N Engl J Med 2002, 347:1412-1418 10.1056/NEJMoa013383 12409543
9. Callen JP Pyoderma gangrenosum Lancet 1998, 351:581-585 10.1016/ S0140-6736(97)10187-8 9492798
10. Brooklyn T Dunnill G Probert C Diagnosis and treatment of pyoderma gangrenosum BMJ 2006, 333:181-184 10.1136/bmj.333.7560.181 16858047
11. Bennett ML Jackson JM Jorizzo JL Fleischer AB Jr White WL Callen JP Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions Medicine (Baltimore) 2000, 79:37-46 10.1097/ 00005792-200001000-00004 10670408
12. Ehling A Karrer S Klebl F Schaffler A Muller-Ladner U Therapeutic management of pyoderma gangrenosum Arthritis Rheum 2004, 50:3076-3084 10.1002/art.20559 15476233
13. Patel GK Rhodes JR Evans B Holt PJ Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream J Dermatolog Treat 2004, 15:122-125 10.1080/09546630310019364 15204166